Blood hibernation: A novel strategy to inhibit systemic inflammation and coagulation induced by cardiopulmonary bypass

Chinese Medical Journal

Volumn 123, Issue 13, 2010, Pages 1741-1747

  Zhou, Jing ^a   Wu, Xiao Dong ^a   Lin, Ke ^a   Lui, Raphael C ^a   An, Qi ^a   Tao, Kai Yu ^a   Du, Lei ^a   Liu, Jin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; Coagulation cascade; Hibernation, blood; Inflammatory response

Indexed keywords

APROTININ; CD11B ANTIGEN; ELASTASE; INTERLEUKIN 8; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE; PROSTAGLANDIN E1; PROTHROMBIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CELL ACTIVATION; CONTROLLED STUDY; DOG; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; NONHUMAN; POSTOPERATIVE INFLAMMATION; PROTEIN BLOOD LEVEL; SYSTEMIC CIRCULATION; THROMBOCYTE ACTIVATION;

ALPROSTADIL; ANIMALS; ANTIGENS, CD11B; APROTININ; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; DOGS; INFLAMMATION; MALE; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954477923     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.13.024     Document Type: Article

References (22)

1. Edmunds LH. Cardiopulmonary Bypass after 50 Years. N Engl J Med 2004; 351: 1603-1606.
2. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997; 63: 277-284.
3. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007; 101: 234-247.
4. Seeburger J, Hoffmann J, Wendel HP, Ziemer G, Aebert H. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Circulation 2005; 112: I224-I228.
5. Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 2003; 107: 2823-2828.
6. El Kebir D, Hubert B, Taha R, Troncy E, Wang T, Gauvin D, et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest 2005; 128: 2910-2917.
7. Chello M, Mastroroberto P, Marchese AR, Maltese G, Santangelo E, Amantea B. Nitric oxide inhibits neutrophil adhesion during experimental extracorporeal circulation. Anesthesiology 1998; 89: 443-448.
8. Kanemitsu S, Nishikawa M, Onoda K, Shimono T, Shimpo H, Yazaki A, et al. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation. J Thorac Cardiovasc Surg 2003; 126: 428-435.
9. Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 2004; 19: 481-488.
10. Dixon B, Santamaria J, Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005; 128: 229-236.
11. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
12. Levi M, ten Cate H, van der Poll T. Endothelium: interface between coagulation and inflammation. Crit Care Med 2002; 30: S220-S224.
13. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
14. Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis. Curr Mol Med 2006; 6: 489-499.
15. Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study. J Thorac Cardiovasc Surg 2005; 129: 782-790.
16. Addonizio VP Jr, Macarak EJ, Niewiarowski S, Colman RW, Edmunds LH Jr. Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass. Circ Res 1979; 44: 350-357.
17. Day JR, Taylor KM, Lidington EA, Mason JC, Haskard DO, Randi AM, et al. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg 2006; 131: 21-27.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidiniumth iocyanatephenol-chloroformex traction. Anal Biochem 1987; 162: 156-159.
19. Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Baenziger O, Dahinden C. Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 2003; 126: 718-725.
20. Khan MM, Gikakis N, Miyamoto S, Rao AK, Cooper SL, Edmunds LH, et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass. Ann Thorac Surg 1999; 68: 473-478.
21. Landis RC, Haskard DO, Taylor KM. New anti-inflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 2001; 72: S1808-S1813.
22. Lissauer ME, Johnson SB, Siuzdak G, Bochicchio G, Whiteford C, Nussbaumer B, et al. Coagulation and complement protein differences between septic and uninfected systemic inflammatory response syndrome patients. J Trauma 2007; 62: 1082-1094.